Nexalin Technology, Inc. (NXL) vs WORK Medical Technology Group Ltd. Class A (WOK)
A side-by-side comparison of Nexalin Technology, Inc. and WORK Medical Technology Group Ltd. Class A across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NXL
Nexalin Technology, Inc.
$4.50HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
WOK
WORK Medical Technology Group Ltd. Class A
$1.50HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — NXL vs WOK
growth of $100 · dividends reinvested · last 2yNXL -81.2% (-56.7%/yr)WOK -100.0% (-99.9%/yr)NXL compounded faster over this window
Log scale — wide-divergence pair
NXL WOK
NXL vs WOK: by the numbers
- •WOK is the larger company ($4M vs $3M market cap).
- •Both run net losses; WOK's is the smaller (-10.89% vs -4139.38% net margin).
- •NXL grew revenue faster over the past five years (10.22% vs -28.44% CAGR).
Metrics side by side
Valuation
| Metric | NXL | WOK |
|---|---|---|
| P/S ratio | 15.20 | N/A |
| P/B ratio | 2.17 | 0.12 |
Profitability
| Metric | NXL | WOK |
|---|---|---|
| Gross margin | 79.65% | 23.81% |
| Operating margin | -2781.69% | -25.34% |
| Net margin | -4139.38% | -10.89% |
| ROE | -591.60% | -5.85% |
| ROIC | -600.62% | -9.04% |
Growth (annualized)
| Metric | NXL | WOK |
|---|---|---|
| Revenue CAGR (5Y) | 10.22% | -28.44% |
Frequently asked
- Which has grown faster, NXL or WOK?
- Over the past five years, NXL grew revenue faster — NXL at a 10.22% CAGR versus WOK at -28.44%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.